Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at the alternatives available when South Korea does not acknowledge safeguards for missing deadlines as provided in the WIPO’s Patent Cooperation Treaty rules -
Sponsored by Spoor & FisherMargaret Le Galle of Spoor & Fisher explains why the Plant Variety Protection Act 2021 will bring Nigerian IP law in line with international norms
-
Sponsored by Cabinet Beau de LoménieFrancis Declercq of Cabinet Beau de Loménie looks at the key tax changes arising from the IP box regime in France
-
Sponsored by RNA, Technology and IP AttorneysRachna Bakhru of RNA Technology and IP Attorneys explains the urgent need for clear regulations surrounding cryptocurrencies and NFTs in India
-
Sponsored by Remfry & SagarCA Brijesh and Shubham Shende of Remfry & Sagar describe why the Indian courts seem to be taking a more lenient view of comparative advertising
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains the patent eligibility of AI-related inventions in Japan
